We are pleased to announce that MS sherpa receives an investment of 1.5 million euros. With the new capital, Sherpa BV will continue to grow independently as a start-up in the Netherlands and Germany and…
News
Newsletters MS sherpa
In April we launched our first MS sherpa newsletter, and we will continue to do so on a quarterly basis. You can find the newsletter from April here (in Dutch). If you also want to…
Pilot MS Sherpa in the Jeroen Bosch Hospital
A pilot with MS Sherpa was carried out in the Jeroen Bosch Hospital. During 4 months, 10 patients and their MS caregivers actively started working with MS Sherpa, during which a weekly cognition and walking…
Jacco Schutte new CEO of MS sherpa BV
On March 1, 2022, Jacco Schutte started as the new CEO of MS sherpa. Jacco has more than 15 years of experience in healthcare and management and will fully use his passion for smart digital…
Launch of MS sherpa at Upendo
On Tuesday, the 15th of February, Upendo signed a contract for using MS sherpa in their clinical practice for MS care. Upendo is a Dutch clinic specializing in “Future-proof care” for people with MS. Upendo’s…
TNN: MS sherpa – measuring mobility and cognition in multiple sclerosis regularly and reliably at home
MS sherpa is featured in the 8th issue of The Dutch Journal of Neurology & Neurosurgery (TNN). Below you will find our advertorial (in Dutch). It describes the tool and highlights the added value of…
Media about MS sherpa: Innovation Origins
Digital biomarkers let doctor see how patients are really doing. With specially developed digital biomarkers, you can measure a patient’s health more objectively. This allows doctors to get a better picture of a patient. Gait…